help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2018
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/2/438    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vestergaard, E. T.
Right arrow Articles by Schmitz, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vestergaard, E. T.
Right arrow Articles by Schmitz, O.
Related Collections
Right arrow Lipid
Right arrow Diabetes and Insulin
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 2 438-444
Copyright © 2008 by The Endocrine Society

Acute Effects of Ghrelin Administration on Glucose and Lipid Metabolism

Esben Thyssen Vestergaard, Christian Born Djurhuus, Jakob Gjedsted, Søren Nielsen, Niels Møller, Jens Juul Holst, Jens Otto Lunde Jørgensen and Ole Schmitz

Medical Department M (Endocrinology and Diabetes) (E.T.V., C.B.D., J.G., S.N., N.M., J.O.L.J.), Aarhus University Hospital, DK-8000 Aarhus C, Denmark; Department of Biomedical Sciences (J.J.H.), the Panum Institute, University of Copenhagen, DK-2200 Copenhagen, Denmark; and Department of Pharmacology (O.S.), University of Aarhus, DK-8000 Aarhus, Denmark

Address all correspondence and requests for reprints to: Esben Thyssen Vestergaard, M.D., Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital, DK-8000 Aarhus C, Denmark. E-mail: e.t.vestergaard{at}ki.au.dk.

Context: Ghrelin infusion increases plasma glucose and nonesterified fatty acids, but it is uncertain whether this is secondary to the concomitant release of GH.

Objective: Our objective was to study direct effects of ghrelin on substrate metabolism.

Design: This was a randomized, single-blind, placebo-controlled two-period crossover study.

Setting: The study was performed in a university clinical research laboratory.

Participants: Eight healthy men aged 27.2 ± 0.9 yr with a body mass index of 23.4 ± 0.5 kg/m2 were included in the study.

Intervention: Subjects received infusion of ghrelin (5 pmol·kg–1·min–1) or placebo for 5 h together with a pancreatic clamp (somatostatin 330 µg·h–1, insulin 0.1 mU·kg–1·min–1, GH 2 ng·kg–1·min–1, and glucagon 0.5 ng·kg–1·min–1). A hyperinsulinemic (0.6 mU·kg–1·min–1) euglycemic clamp was performed during the final 2 h of each infusion.

Results: Basal and insulin-stimulated glucose disposal decreased with ghrelin [basal: 1.9 ± 0.1 (ghrelin) vs. 2.3 ± 0.1 mg·kg–1·min–1, P = 0.03; clamp: 3.9 ± 0.6 (ghrelin) vs. 6.1 ± 0.5 mg·kg–1·min–1, P = 0.02], whereas endogenous glucose production was similar. Glucose infusion rate during the clamp was reduced by ghrelin [4.0 ± 0.7 (ghrelin) vs. 6.9 ± 0.9 mg·kg–1·min–1; P = 0.007], whereas nonesterified fatty acid flux increased [131 ± 26 (ghrelin) vs. 69 ± 5 µmol/min; P = 0.048] in the basal period. Regional lipolysis (skeletal muscle, sc fat) increased insignificantly with ghrelin infusion. Energy expenditure during the clamp decreased after ghrelin infusion [1539 ± 28 (ghrelin) vs. 1608 ± 32 kcal/24 h; P = 0.048], but the respiratory quotient did not differ. Minor but significant elevations in serum levels of GH and cortisol were observed after ghrelin infusion.

Conclusions: Administration of exogenous ghrelin causes insulin resistance in muscle and stimulates lipolysis; these effects are likely to be direct, although a small contribution of GH and cortisol cannot be excluded.




This article has been cited by other articles:


Home page
DiabetesHome page
E. T. Vestergaard, L. C. Gormsen, N. Jessen, S. Lund, T. K. Hansen, N. Moller, and J. O. L. Jorgensen
Ghrelin Infusion in Humans Induces Acute Insulin Resistance and Lipolysis Independent of Growth Hormone Signaling
Diabetes, December 1, 2008; 57(12): 3205 - 3210.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Gjedde, E. T. Vestergaard, L. C. Gormsen, A. L. D. Riis, J. Rungby, N. Moller, J. Weeke, and J. O. L. Jorgensen
Serum Ghrelin Levels Are Increased in Hypothyroid Patients and Become Normalized by L-Thyroxine Treatment
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2277 - 2280.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society